Detection of ctDNA ranges from 62% to 65.7% sensitivity for EGFR mutations in NSCLC[3,25] and from 25% to 41% sensitivity for KRAS mutations in CRC[26,27]. This evidence concerns the gene KRAS and colorectal carcinoma.